chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Slept all day Saturday and felt fine on Sunday; Felt a little dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 26Mar2021 (Batch/Lot number: unknown) at the age of 51 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, administration time: 13:00, lot number: ER2613, expiry date: 31Jul2021, administered in left arm), administration date: 05Mar2021, for COVID-19 immunisation, reaction(s): "Dizzy", "Headache". The following information was reported: DIZZINESS (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Felt a little dizzy"; SOMNOLENCE (non-serious) with onset 27Mar2021, outcome "recovered" (28Mar2021), described as "Slept all day Saturday and felt fine on Sunday". Therapeutic measures were not taken as a result of dizziness, somnolence.  Additional information: The patient had no additional vaccines administered on the same date of BNT162B2 and had not received any other vaccines within 4 weeks prior vaccination. The patient denied any medications, medical conditions, labs, testing or treatments relevant to the events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Cellulitis of left posterior thigh developed few days after MMR injection - required course of antibiotics to treat.
This spontaneous report was received from a consumer and refers to her daughter, a 12 month old female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 29-JAN-2018, the patient was vaccinated with VARIVAX lot # N023957, expiration date 01-SEP-2019 (dose, route of administration and anatomical location were not reported) as a chicken pox vaccine (prophylaxis). On 07-FEB-2018, the patient developed chicken pox. It was reported that the patient did not receive any medical attention, no treatment was provided and that any Laboratory diagnostics or studies were performed. At the reporting time, the patient had not recovered from the event varicella post vaccine and the reporter did not assess the causal relationship between therapy with VARIVAX and the event.
INTENSE PAIN AND FLU-LIKE SYMPTOMS AFTER 12 HOURS, BUT ALSO EXPERIENCED UTI AND YEAST INFECTION LESS THAN TWO WEEKS AFTER SECOND DOSE, CLEARED WITH MEDICATION PRESCRIPTIONS.
Patient has a big rash on her left arm, hot to touch, swollen area and itchy. It started couple hours after the shot, She reported it at the pharmacy  24 hours after the vaccine.
Information has been received from a physician concerning an 8 or 9 yr old male who sometime in the late 1990's was vaccinated with a dose of varicella virus vaccine live. Subsequently, on an unspecified date the pt developed full blown chickenpox. Unspecified medical attention was sought. At the time of this report the pt's present status was not recovered. No product quality complaint was involved. Additional information has been requested.
Patient presented to ED with complaint of chest pain, radiating down left arm, not relieved with Tums.  Symptoms started at 0530 1/12/2020.  Patient presented to ED b/c of strong family history of CAD, with father having MI in his 50s.
she started to feel inflamed around the injection site; she started to feel itchy around the injection site; she started to feel a rash around the injection site; A bit of a sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Apr-2021 and was forwarded to Moderna on 08-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A bit of a sore arm), VACCINATION SITE INFLAMMATION (she started to feel inflamed around the injection site), VACCINATION SITE PRURITUS (she started to feel itchy around the injection site) and VACCINATION SITE RASH (she started to feel a rash around the injection site) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (A bit of a sore arm). On 08-Apr-2021, the patient experienced VACCINATION SITE INFLAMMATION (she started to feel inflamed around the injection site), VACCINATION SITE PRURITUS (she started to feel itchy around the injection site) and VACCINATION SITE RASH (she started to feel a rash around the injection site). At the time of the report, PAIN IN EXTREMITY (A bit of a sore arm), VACCINATION SITE INFLAMMATION (she started to feel inflamed around the injection site), VACCINATION SITE PRURITUS (she started to feel itchy around the injection site) and VACCINATION SITE RASH (she started to feel a rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
after administration dull pain in left arm then patient started sweating and feeling nauseous. Patient sat down and  BP was taken ( 80/41), patient was feeling nauseous and dizzy. 1 minute later BP was 60/43 and then 77/49. Patient passed out, we called 911 and 30 seconds later patient came to. EMS arrived 8 minutes later and BP was 119/71 when he left. Patient reported feeling fine and denied going to hospital.
I got my second dose of Phizer May 10th at facility. May 16th I started to have back pain over my left kidney. May 17th the pain was unbearable at night. I was not able to sleep. I went to the Clinic May 18th at 9am. I was diagnosed with Shingles.
This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 01-SEP-2015, the patient was vaccinated with an improperly stored dose of VAQTA (dose and route were not reported, lot # L009445, expiration date 01-JUN-2017). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Left arm pain, with cirucular red area, warmth and itching. Started 8 days after administration.
rash at injection site; radiating towards elbow; raised; hot; itchy; injection site was sore; injection site was hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (radiating towards elbow), INJECTION SITE REACTION (injection site was hard), SWELLING (raised), VACCINATION SITE WARMTH (hot) and PRURITUS (itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hay fever.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Dec-2020, the patient experienced INJECTION SITE REACTION (injection site was hard) and INJECTION SITE PAIN (injection site was sore). On 04-Jan-2021, the patient experienced VACCINATION COMPLICATION (radiating towards elbow), SWELLING (raised), VACCINATION SITE WARMTH (hot) and PRURITUS (itchy). On 04-Feb-2021, the patient experienced RASH (rash at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency; MELOXICAM at an unspecified dose and frequency and METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (radiating towards elbow), INJECTION SITE REACTION (injection site was hard), SWELLING (raised), VACCINATION SITE WARMTH (hot), PRURITUS (itchy), INJECTION SITE PAIN (injection site was sore) and RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products information provided    This case was linked to US-MODERNATX, INC.-MOD-2021-032970 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-032970:2nd dose vaccine
The next morning after injection, my mental function was affected. According to my mental function, I felt very tired while reading a book or driving. In fact, the next day after the infection, I was unable to drive at all. I could not work because of my mental function. My memory was affected. I would forget things easily. I had a hard time holding a prolonged conversation with anybody. I just got really tired very easily. I could not function the day after injection.  Along with this, I was very lightheaded. If I stood up or walked I felt like my legs would give way and I would fall down to the floor. I didnt' have physical strength to stand or walk for more than a few minutes. I was extremely lightheaded.
11-12-08 DX with pharyngitis, strep test negative.  Reported enlarged lymph nodes, extreme fatigue, stiff neck.  Symptoms onset on or around 11-10-08.  Improved energy by 11-13-08.  Return to on 11/14/08.  On 10-31-08 c/o nausea 20 minutes after shot, went away.
This spontaneous report was received from a healthcare worker regarding a patient of unknown age and gender. There was no information on pertinent medical history and drug reactions or allergies. On 25-NOV-2014, the patient was vaccinated with ZOSTAVAX (dose, route, product lot#, expiry date not reported). The reporter stated that one dose of ZOSTAVAX was administered to patient after being improperly stored. No adverse effects reported. There was no product quality complaint involved. The outcome of the events was unknown. Additional information has been requested.
Patient is a 71 y.o. male who presents to the ED with complaint of moderate left flank pain.  Dull.  Has been going on for a few of days.  He thought he might have a kidney stone although he has no history of kidney stones.  He walked in.  Pain radiates down to his left lower quadrant.  He is also had some pain in his left shoulder blade.  Denies fevers cough or shortness of breath.  It does hurt when he takes of breath.  Has been vaccinated for Covid including the booster.  He reports a little bit of bilateral leg edema.  No real calf tenderness.  He is not had any hematuria.  He was getting an outpatient CT but was going to have to wait 48 hours to get 1 and the pain was becoming too much and nagging. Diagnosis of bilateral pulmonary embolism. treated with one dose of lovenox. eliquis 5mg Take 2 pills bid for 7 days and then 1 pill bid for 30 days.
3 AM after receiving vaccine pt woke having an asthma attack-used her inhaler-had a fever of 101.5-used cool compress-also nauseated- talked with her 12/22 730pm- doing fine now.
14 yo female fainted for seconds and fell back post vaccine admin. - head hit floor when fell - Required lying in exam room until able to get up without c/o HA or dizziness - Had only eaten a bagel in am and then run mile before appoint.  Given coca cola to drink and hard candy.
Eyes red and itchy - slight swelling of eyes all day.  Prescribed Tavist syrup, 2 doses; symptoms resolved completely.
With initial vaccination pt had significant swelling of whole (L) arm which resolved. Since that time pt has had persistent intermittent sharp jabbing pains to (L) arm, centered at injection site.
Big bruise that is moving down my upper arm.  Felt pain during injection.  Possibly hit a vein?  Bruise appeared 3-4 days after injection and arm is still sore 11 days after the injection.  I only weigh 90 lbs. and have skinny arms.
Patient stated her after she received the vaccine she felt her arm sore and it appeared pink and puffy. It was tender to touch.
rash developed one week after injection, surrounding the injection site...about 3 inches in diameter.  Itches and a little sore. vaccinated 1/19, rash started 1/26.
Patient has a history of Reiter's Syndrome. Roughly 24 hours after vaccination patient started experiencing headaches, extreme fatigue, lightheadedness, PVC's, and shortness of breath. Pt has also been experiencing numbness and tingling in his hands due to increased inflammation around his spine and radial nerve.
4 days after vaccine, started to feel really sick (fever, nausea, chills, muscle pain, headache), then later in the day my left foot started to develop a tingling sensation that turned into my foot becoming numb in the toes and the bottom of the foot. Sharp tingling pain in left foot every once in a while. If standing or walking for long periods of time, my foot starts to ache along the part where toes are attached (mid met?). While the flu/sickness symptoms went away on 2/20/23, my left foot is still numb and tingling. I went to urgent care today (2/24/2023), and the doctor there diagnosed me with nerve damage and then prescribed me non-steroid anti-inflammation medicine for 10 days to see if symptoms would subside. I was told if symptoms did not go away in 10 days, I would need to see a neurologist. At this time, my left foot is still numb/tingly/aching.
This initial non-serious spontaneous case, was received on 01-Nov-2017, from a physician, concerning an adult male patient of unspecified age. This refers to 58 of 84 patients. On an unspecified date in Oct-2017 (between 25-Oct-17 to 27-Oct-17), the patient was administered with AFLURIA (TIV) Thiomersal (batch number: 14649211A, dose, route of administration, anatomical location and expiry date: not reported). It was reported that, the vaccine was stored in a cooler with ice packs for 6 days and had reached unknown temperature during transport (explicitly considered as incorrect product storage) instead of storing at 36-degree F and 46-degree F (2-degree C and 8-degree C). And the same was administered to the patient (explicitly considered as drug administration error). The reporter stated that the temperature was not monitored on 24-Oct-2017 (could have been between 2-8C, but not certain) and there were no reports of adverse effect after vaccination. The vaccine had been discarded. Follow up received on 09-Nov-2017 from a physician: Added event (no adverse effect) and reporter's comment. Amended narrative accordingly.
Pt. was given Pnu-Imune 23 on 11/9/99. One week later, developed "pneumonia-like symptoms" and was hospitalized. Pt. was tx'd & released. This is 1 of 2 pts. from this facility who had adverse experience from Pnu-Imune 23 Vaccine.
Patient presented to office 10/26/17 with lump, redness, tenderness and warm of right upper arm. Patient notes that several days prior she received her PPSV in that arm.
Headache, Arthralgia, Localized swelling; fatigue Narrative:  Other Relevant History:
There was erythema and swollen from wrist to shoulder. Numbness and low range of motion.
Currently on dose 3 of 4. Taking in the morning before eating and waiting 90 min to eat or drink anything. Since first dose, near-constant nausea (without vomiting) and appetite loss. Intermittent abdominal cramping (2-3x daily, lasting 2-15 minutes) of varying severity (typically moderate, ie distracting but not entirely disabling), generally in the lower abdomen. Looser stool than usual, but no diarrhea.
This is a spontaneous report from a contactable other healthcare professional via Pfizer Sales representative. A 16-year-old female patient of unspecified ethnicity received TRUMENBA at 0.5 ml single, MENACTRA and HPV9 all via an unspecified route of administration, on unknown date. Relevant medical history and concomitant medications were not reported. After the vaccination, on unknown date, the passed out for a few seconds. The outcome of the event was unknown.
Injection (TDaP) done on 3/7/17. On Wednesday 3/8/17 noted redness and tenderness to injection site. Also, when head was turned to right a sharp pain radiated from right lower neck to top of head on right side. The redness and tenderness spread daily.
So I started to notice a dry cough, after the vaccine. I started feeling feverish and hurting. An then started to have a running nose and a discomfort and it would start in the evening and it's not going anywhere. He said that the doctor prescribe me some Doxycycline to take twice a day.
Got really uncomfortable around 5-6 pm and gave tylenol Around 8 pm started having full body spasms They occurred every 30-45 seconds It slowed down to every 2 minutes and was able to fall asleep around 2-3 am Alert throughout, no eye deviation, no c; Got really uncomfortable around 5-6 pm and gave tylenol Around 8 pm started having full body spasms They occurred every 30-45 seconds It slowed down to every 2 minutes and was able to fall asleep around 2-3 am Alert throughout, no eye deviation, no c; Got really uncomfortable around 5-6 pm and gave tylenol Around 8 pm started having full body spasms They occurred every 30-45 seconds It slowed down to every 2 minutes and was able to fall asleep around 2-3 am Alert throughout, no eye deviation, no c; Got really uncomfortable around 5-6 pm and gave tylenol Around 8 pm started having full body spasms They occurred every 30-45 seconds It slowed down to every 2 minutes and was able to fall asleep around 2-3 am Alert throughout, no eye deviation, no c; This case was retrieved during monitoring on 12-APR-2023 with the following Primary 2591780-1. The original narrative from the sender is as follows:  Got really uncomfortable around 5-6 pm and gave tylenol Around 8 pm started having full body spasms They occurred every 30-45 seconds It slowed down to every 2 minutes and was able to fall asleep around 2-3 am Alert throughout, no eye deviation, no color change or weakness Could not breastfeed due to spasms Parents called on call Nurse and spoke with on Call Doctor, given option to  monitor at home or go to ER. Parents chose to monitor at home over night.  The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events. No further information is expected.
Patient states history of vasovagal syncope and felt dizzy. Patient observed for 25 minutes and released to leave after stating she felt better.
Shingles reported to doctor's office 15DEC2021. It appeared within the week before that.
The 2nd shot was very high on my shoulder and painful; unable to move my left arm or fingers without excruciating pain; unable to move my left arm or fingers without excruciating pain; limited movement; it keeps me awake at night.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 27Feb2021 09:15 (at the age of 43-Years-old) (Batch/Lot Number: EM9809) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was reported as none. Concomitant medication included doxycycline 40 mg taken for an unspecified indication, start and stop date were not reported. Allergies were not known. Patient did not have Covid prior to vaccination. Patient was not tested for covid after vaccination. Patient did not receive any other vaccine in four weeks. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 06Feb2021 01:30 pm (at the age of 43-Years-old) (Batch/Lot Number: EL3247) as DOSE 1, SINGLE for covid-19 immunisation. On 27Feb2021 at 10:00, within 1 hour after second shot, the patient experienced the 2nd shot was very high on my shoulder and painful, unable to move my left arm or fingers without excruciating pain, limited movement. On the same day it kept her awake at night. It was reported that some movement gradually returned, but she was 2 weeks out from the vaccine and still had shoulder pain and limited movement so much so that it keeps her awake. No therapeutic measures were taken with respect to events. At the time of this report, the outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
General not feeling well, stomach ache, headache, sore throat; didn't take temperature until after school at 3:50 and was 99.5.  Reported not feeling well all day and frequent urination as well.
Patient stated that he received the Moderna Covid-19 Vaccine on 11/29/2021, then within a few hours, started to experience severe headaches.   Patient rated headaches as an 8-9 out of 10 on the pain scale, and described as mostly dull but sometimes throbbing.   Patient stated that the headaches are constant and not relieved by OTC Tylenol and/or ibuprofen.   Patient denies having a history of migraine headaches.   Patient also complains of having left rib pain, which resulted in him blacking out on 12/04/2021.   Patient was transported to the ER by ambulance.   Patient stated that they conducted testing there and was not able to find anything wrong at that time.   Patient also complains of redness and itching that is not his usual after shaving.   Patient also complains of non-stop joint aching.--in all joints.   .  Patient denies having a history of any chronic conditions.
Pt stated that she experienced a rash on her breast that slowly went away but then started to feel a tingle at her breast area. Pt consulted to get evaluated by MD to get a second opinion since this may due to another reason.
Large, red, firm, swelling at site with ? of 2 hives on back. Clearing with Benadryl and ice.
Periencing pressure in the neck area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL DISCOMFORT (non-serious), outcome "unknown", described as "Periencing pressure in the neck area".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Chills; Fever; Aches; Flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of chills in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (first dose received on an unknown date).   On 22nd November 2022, the patient received the 2nd dose of Shingrix. In November 2022, less than a week after receiving Shingrix, the patient experienced chills, fever, pain and influenza-like symptoms. On an unknown date, the outcome of the chills, fever, pain and influenza-like symptoms were unknown.   It was unknown if the reporter considered the chills, fever, pain and influenza-like symptoms to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR175866   Additional Information: GSK Receipt Date: 23-NOV-2022 Reporter's Comments:  The case was self reported by the patient.  The patient received her second dose of Shingrix on the day before the reporting. The patient experienced fever, chills, aches, and flu like symptoms.  The patient did not experience adverse effects from the first dose.  The adverse event was filed. The reporter was consented to follow up. This case had been linked with US2022AMR175866 same patient. Note: Outcome for the event chills was captured as unknown as in structured field reported as fatal but as per narrative did not seems that patient was died as reporter was patient.; Sender's Comments:  US-GSK-US2022AMR175866:same reporter